Market Overview

Bank of America Maintains Buy on Durata Therapeutics, Inc., Raises PO to $14.00

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for DRTX

DateFirmActionFromTo
Oct 2014Roth CapitalDowngradesBuyNeutral
Oct 2014Credit SuisseDowngradesOutperformNeutral
Oct 2014RBC CapitalDowngradesOutperformSector Perform

View More Analyst Ratings for DRTX
View the Latest Analyst Ratings

Posted-In: News Price Target Analyst Ratings

 

Related Articles (DRTX)

Around the Web, We're Loving...

Get Benzinga's Newsletters

Benzinga Professional